Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study
Vascular Pharmacology · 2025
DOI: 10.1016/j.vph.2025.107529 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Vascular Pharmacology, 2025. Verfasst von Livio Giuliani und 19 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology, Haemodynamic and Cardiac Intensive Care Unit, San Salvatore Hospital, L'Aquila, Italy. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Connective Tissue Diseases, Sulfonamides, Pyrazines. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) is a progressive, high-risk subtype of PAH characterized by immune-mediated vascular remodeling, poor treatment response, and reduced survival. Real-world data on therapeutic response and risk evolution in this population remain limited. METHODS: This post hoc analysis of the multicenter, prospective INSPECTIO study evaluated the CTD-PAH subpopulation treated with macitentan and/or selexipag. The primary endpoint was the change in the number of non-invasive low-risk criteria (World Health Organization functional class I-II, 6-min walk distance >440 m, BNP
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology, Haemodynamic and Cardiac Intensive Care Unit, San Salvatore Hospital, L'Aquila, Italy.
- Department of Cardiology, Monaldi Hospital, Naples, Italy.
- Hospital Santa Maria della Misericordia, Rheumatology Unit, University of Udine, Udine, Italy.
- Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
- S.O.D. Clinic of Cardiology and Arithmology, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy.
- Cardiology Department and Cardiac Intensive Care Unit, San Michele Hospital, A.O. Brotzu, Cagliari, Italy.
Zitieren
APA
Giuliani, L., D'Alto, M., Di Poi, E., Dagna, L., Guerra, F., Corda, M., Perna, G. P., Doria, A., Badagliacca, R., Vicenzi, M., Airò, E., Toma, M., Scelsi, L., Piccinino, C., Brunetti, N. D., Lombardi, C. M., Baldi, F., Biancospino, M., Uglietti, A., & De Santis, S. (2025). Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2025.107529
Vancouver
Giuliani L, D'Alto M, Di Poi E, Dagna L, Guerra F, Corda M, et al. Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study. Vascular Pharmacology. 2025. doi:10.1016/j.vph.2025.107529
BibTeX
@article{Giuliani2025,
author = {Giuliani, Livio and D'Alto, Michele and Di Poi, Emma and Dagna, Lorenzo and Guerra, Federico and Corda, Marco and Perna, Gian Piero and Doria, Andrea and Badagliacca, Roberto and Vicenzi, Marco and Airò, Edoardo and Toma, Matteo and Scelsi, Laura and Piccinino, Cristina and Brunetti, Natale Daniele and Lombardi, Carlo Mario and Baldi, Fabiana and Biancospino, Matteo and Uglietti, Alessia and De Santis, Stefano},
title = {Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study},
journal = {Vascular Pharmacology},
year = {2025},
doi = {10.1016/j.vph.2025.107529}
}
EUVIMED